APA (7th ed.) Citation

Gerald HJ Mickisch, Björn Schwander, Bernard Escudier, & et al. (2011). Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy. Dove Medical Press.

Chicago Style (17th ed.) Citation

Gerald HJ Mickisch, Björn Schwander, Bernard Escudier, and et al. Indirect Treatment Comparison of Bevacizumab + Interferon-α-2a Vs Tyrosine Kinase Inhibitors in First-line Metastatic Renal Cell Carcinoma Therapy. Dove Medical Press, 2011.

MLA (9th ed.) Citation

Gerald HJ Mickisch, et al. Indirect Treatment Comparison of Bevacizumab + Interferon-α-2a Vs Tyrosine Kinase Inhibitors in First-line Metastatic Renal Cell Carcinoma Therapy. Dove Medical Press, 2011.